The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: A single unit, extracellular recording study

Synapse

Volumn 22, Issue 1, 1996, Pages 35-45

  Minabe, Yoshio ^a   Emori, Kenji ^a   Toor, Alon ^b   Stutzmann, Grace E ^c   Ashby Jr , Charles R ^b  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Electrophysiology; Substance P; Substantia nigra pars compacta; Ventral tegmental area

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; APOMORPHINE; DOPAMINE; NEUROKININ 1 RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG SELECTIVITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE UNIT ACTIVITY; SPIKE; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; APOMORPHINE; BIPHENYL COMPOUNDS; DOPAMINE; DOPAMINE AGONISTS; ELECTROPHYSIOLOGY; EXTRACELLULAR SPACE; HYPNOTICS AND SEDATIVES; MALE; MEMBRANE POTENTIALS; MESENCEPHALON; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA;

EID: 0030052525     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199601)22:1<35::AID-SYN4>3.0.CO;2-J     Document Type: Article

References (56)

1. 3 receptor antagonist BRL 46470A on the number of spontaneously active midbrain dopamine cells in the rat. Drug Dev. Res., 31:228-236.
2. Bannon, M.J., Elliott, P.J., Alpert. J.E., Goedert, M., Iversen, S.D., and Iversen, L.L. (1983) Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurons. Nature, 306:791-792.
3. Bunney, B.S. and Grace, A.A. (1978) Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity Life Sci., 23:1715-1728.
4. Bunney, B.S., Walter, J.R., Roth, R.H., and Aghaganian, G.K. (1973) Dopaminergic neurons: Effect of antipsychotic drugs and amphetamines on single cell activity. J. Pharmacol. Exp. Ther, 175:560-571.
5. Cheramy, A., Michelot, R., Leviel, V., Nieoullon, A., Glowinski, J., and Kerdelhue, B. (1978) Effect of the immunoneutralization of substance P in the cat substantia nigra on the release of dopamine from dendrites and terminals of dopaminergic neurons. Brain Res., 155:404-408.
6. Chiodo, L.A. (1988) Dopamine-containing neurons in the mammalian central nervous system: Electrophysiology and pharmacology. Neurosci. Biobehav., Rev., 12:49-91.
7. Chiodo, L.A. and Bunney, B.S. (1983) Typical and atypical neuroleptics-differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci., 3: 1607-1619.
8. Cuello, A.C. and Kanazawa, I. (1978) The distribution of substance P immunoreactive fibres in the rat central nervous system. J. Comp. Neurol., 178:129-156.
9. Cuello, A.C., Emson, P.C., Paxinos, G., and Jessell, T. (1978) Substance P containing and cholinergic projections from the habenula. Brain Res., 149:413-429.
10. Deal, M.J., Hagan, R.M., Ireland, S.J., Jordan, C.C., McElroy, A.B., Porter, B., Ross, B.C., Smith, S., and Ward, P. (1992) Conformationally constrained tachykinin analogues: Effect and highly selective neurokinin NK-2 receptor agonists. J. Med. Chem., 35:4195-4204.
11. 3 receptor. Life Sci. (Pharmacol. Lett.), 56:PL27-32.
12. Elliott, P.J. and Iversen, S.D. (1986) Behavioral effects of tachykinins and related peptides. Brain Res., 381:68-72.
13. Elliott, P.J., Mason, G.S., Stephens-Smith, M., and Hagan, R.M. (1991) Behavioral and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists. Neuropeptides, 19:119-126.
14. Fadda, F., Argiolas, A., Melis, M.R , Tissari, A.H., Onali, P.L., and Gessa, G.L. (1978) Streaa-indueed increase in 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in the nucleus accumbens: Reversal by diazepam. Life Sci., 37:2507-2516.
15. Freeman, A.S. and Bunney, B.S. (1987) Chronic neuroleptic effects on dopamine neuron activity: A model for predicting therapeutic efficacy and side effects. Psychopharmacol. Ser., 3:225-235.
16. Gariano, R.F. and Groves, P.M. (1988) Burst firing induced in midbrain DA neurons by stimulation of medial prefrontal and anterior cingulate cortices. Brain Res., 462.194-198.
17. Garret, C., Carruette, A., Fardin. V., Moussaoui, S., Peyronel, J.-F., Blanchard, J.-C, and Laduron. P.M. (1991) Pharmacological properties of a effect and selective nonpeptide substance P antagonist. Proc. Natl. Acad. Sci., U.S.A., 88:10208-10212.
18. Grace, A.A. (1988) In vivo and in vitro intracellular recordings from rat midbrain dopamine neurons. Ann. N.Y. Acad. Sci., 537:51-76.
19. Grace, A.A. (1992) The depolarization block hypothesis of neuroleptic action: Implications for the etiology and treatment of schizophrenia. J. Neural Transm., 36:91-131.
20. Grace, A.A. and Bunney, B.S. (1984) The control of firing pattern in nigral dopamine neurons: Burst firing. J. Neurosci., 4:2877-2890.
21. Grace, A.A. and Bunney, B.S. (1986) Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: Analysis using in vivo intracellular rewarding. J. Pharmacol. Exp. Ther, 238:1092-1100.
22. 3 receptor antagonists: A critical update on therapeutic effectial. Trends Pharmaeol. Sci., 14:265-270.
23. Hagan, R.M., Ireland, S.J., Jordan, C.C., Beresford, I.J.M., Deal, M.J., and Ward, P. (1991) Receptor-selective, peptidase resistant agonists at neurokinin NK-1 and NK-2 receptors: New tools for investigating neurokinin function. Neuropeptides, 19:127-135.
24. Halliday, G. and Tork, I. (1988) Substance P-like immunoreactive fibers in the ventromedial mesencephalic tegmentum of the rat. Brain Res. Bull., 21:659-670.
25. Hand, T.H., Hu, X.-T. and Wang, R.Y. (1987) Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Brain Res., 415 257-269.
26. Hong, J.S., Yang, H.Y., Racagni, G., and Costa, E. (1977) Projections of substance P containing neurons from neostriatum to substantia nigra. Brain Res. 122:541-544.
27. Kanazawa, I., Emson. P.C., and Cuello, A.C. (1977) Evidence for the existence of substance P-containing fibers in the strionigral and pallido-nigral pathways in the rat. Brain Res., 119:447-453.
28. Kawai, Y., Takagi, H., Kumoi, Y., Shiosaka, S., and Tohyama, M. (1987) Nigrostriatal dopamine neurons receive substance P-ergic inputs in the substantia nigra: Application of the immunoelectron microscopic mirror technique to fluorescent double-staining for transmitter-specific projections Brain Res., 401:371-376.
29. Kelley, A.E., Stinus, L., and Iversen, S.D. (1979) Behavioral activation induced by the rat by substance P infusion into ventral tegmental area: Implication of dopaminergic VTA neurons. Neurosci. Lett., 11:335-339.
30. Kolino, J., Shiosaka. S., Inagaka, S., and Tohyama, M. (1984) Two distinet strionigral substance P pathways in the rat: An experimental immunohistochemical study. Brain Res., 401:371-376.
31. Lisoprawski, A., Blanc, G., and Glowinski, J. (1981) Activation by stress of the habeunle-interpeduncular substance P neurons in the rat. Neurosci. Lett., 25:47-51.
32. Ljungdahl, A., Hokfelt, T., Nilsson, G., and Goldstein, M. (1978) Distribution of substance P-like immunoreactivity in the central nervous system of the rat. II. Light microscopic localization in relation to catecholamine-containing neurons. Neuroscience, 3:945-976.
33. Maeno, H., Kiyama, H., and Tohyama, M. (1993) Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. Mol. Brain Res., 18:43-58.
34. Mahalik, T.J. (1988) Direct demonstration of interactions between substance P immunoreactive terminals and tyrosine hydroxylase immunoreactive neurons in the substantia nigra of the rat An ultrastructural analysis. Synapse, 2:508-510.
35. Matthysse, S. (1973) Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed. Proc., 32:200-205.
36. 1) receptor antagonist. Science, 251.437-439.
37. Meltzer, H.Y. and Stahl, S.M. (1976) The dopamine hypothesis of schizophrenia: A review. Schizo. Bull., 2:19-76.
38. 3 receptor antagonist, on the number of spontaneously active midbrain dopamine neurons. Eur. J. Pharmacol., 209:151-156.
39. 3 receptor antagonists LY 277359 and granisetron effectiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells. Eur. J. Pharmacol., 209:143-150.
40. Minabe, Y., Ashby, Jr., C.R., and Wang, R.Y. (1992) Effects produced by acute and chronic treatment with granisetron alone or in combination with haloperidol on midbrain dopamine cells. Eur. Neuropsychopharmacology, 2:127-133.
41. Overton, P., Elliott, P.J., Hagan, R.M., and Clark, D. (1992) Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat. Eur. J. Pharmacol., 213:165-166.
42. Paxmos, G. and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
43. Pitts, D.K., Kelland, M.E., Shen, R.Y., Freeman, A.S., and Chiodo, L.A. (1990) Statistical analysis of dose-response curves in extracellular electrophysiological studies of single neurons. Synapse, 5:281-291.
44. Pucak, M.L. and Grace, A.A. (1994) Evidence that systematically administered antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. J. Pharmacol. Exp. Ther., 271:1181-1192.
45. B antagonist LY262691 decreases midbrain dopamine unit activity. Eur. J. Pharmacol., 209:135-138.
46. Regoli, D., Boudon, A., and Fauchere, J.-L. (1994) Receptors and antagonists for substance P and related peptides. Pharmacol. Rev., 46:551-599.
47. 2+ channels. Eur. J. Pharmacol., 215:351-352.
48. 1) receptor Science, 251:135-137.
49. 2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: Behavioral, electrophysiological and neurochemical studies. J. Pharmacol. Exp. Ther., 266:684-691.
50. Stinus, L., Kelley, A.E., and Inversen, S.D. (1978) Increased spontaneous activity following substance P infusion into the Al0 dopaminergic area. Nature, 276:616-618.
51. Tamiya, R., Harada, M., Kawai, Y, Inagaki, S., and Takagi, H. (1990) Substance P afferents have synaptic contacts with dopaminergic neurons in the ventral tegmental area of the rat. Neurosci. Lett., 110:11-15.
52. Thierry, A.M., Tassin, J.P., Blanc, G., and Glowinski, J. (1976) Selective activation of the mesocortical dopaminergic system by stress. Nature, 263:242-244.
53. Ward, P., Ewan, G.B., Jordan, C.C., Ireland, S.J., Hagan, RM., and Brown, J.R. (1990) Effect and highly selective neurokmin antagonists. J. Med. Chem., 33:1848-1851.
54. White, F.J. and Wang, R.Y. (1983a) Comparison of the effect of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sci., 32:983-993.
55. White, F.J. and Wang, R.Y. (1983b) Differential effects of classical and atypical antipsychotic drugs on A9 and Al0 dopamine neurons. Science, 225:1054-1057.
56. White, F.J. and Wang, R.Y. (1984) A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci., 34:1161-1170.